Virios Therapeutics, Inc.·4

Jun 22, 5:05 PM ET

Walsh Angela 4

4 · Virios Therapeutics, Inc. · Filed Jun 22, 2021

Insider Transaction Report

Form 4
Period: 2021-06-21
Walsh Angela
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-21+30,00030,000 total
    Exercise: $6.78Exp: 2031-06-21Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The stock option vests one-third on June 21, 2022 and 1/24th monthly thereafter.

Documents

1 file
  • 4
    form4-06222021_020636.xmlPrimary